|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online May 21, 2007
doi: 10.1242/10.1242/jcs.03450
Commentary |
1 Dipartimento di Medicina Sperimentale e Diagnostica, Centro Interdipartimentale per la Ricerca sul Cancro, Università di Ferrara, via Luigi Borsari 46, 44100 Ferrara, Italy
2 Comprehensive Cancer Center, Ohio State University, Columbus OH 43210, USA
* Author for correspondence (e-mail: ngm{at}unife.it)
Accepted 2 April 2007
Numerous miRNAs are deregulated in human cancers, and experimental evidence indicates that they can play roles as oncogenes or tumor suppressor genes. Similarly to cancer genes that encode proteins, deregulation of miRNA-encoding genes is associated with genetic or epigenetic alterations, such as deletions, amplifications, point mutations and aberrant DNA methylation. The discovery that miRNAs interact with known oncogenes has established further links with molecular pathways implicated in malignant transformation. Finally, miRNAs can be used as diagnostic markers, and their potential as therapeutic molecules has moved miRNAs from the area of basic research to the field of cancer biotechnology.
Key words: microRNA, Cancer, Microarray, Oncogenes, Tumor suppressor genes
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Paul, S. J. Seedhouse, and M. D. Disney Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside-RNA hairpin loop interactions Nucleic Acids Res., September 2, 2009; (2009) gkp594v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gramantieri, F. Fornari, M. Ferracin, A. Veronese, S. Sabbioni, G. A. Calin, G. L. Grazi, C. M. Croce, L. Bolondi, and M. Negrini MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality Clin. Cancer Res., August 15, 2009; 15(16): 5073 - 5081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fornari, L. Gramantieri, C. Giovannini, A. Veronese, M. Ferracin, S. Sabbioni, G. A. Calin, G. L. Grazi, C. M. Croce, S. Tavolari, et al. MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells Cancer Res., July 15, 2009; 69(14): 5761 - 5767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xin, M. Li, C. Balch, M. Thomson, M. Fan, Y. Liu, S. M. Hammond, S. Kim, and K. P. Nephew Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance Bioinformatics, February 15, 2009; 25(4): 430 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Siebolts, H Varnholt, U Drebber, H-P Dienes, C Wickenhauser, and M Odenthal Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR J. Clin. Pathol., January 1, 2009; 62(1): 84 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kong, H. Yang, L. He, J.-j. Zhao, D. Coppola, W. S. Dalton, and J. Q. Cheng MicroRNA-155 Is Regulated by the Transforming Growth Factor {beta}/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA Mol. Cell. Biol., November 15, 2008; 28(22): 6773 - 6784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kuchenbauer, R. D. Morin, B. Argiropoulos, O. I. Petriv, M. Griffith, M. Heuser, E. Yung, J. Piper, A. Delaney, A.-L. Prabhu, et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model Genome Res., November 1, 2008; 18(11): 1787 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Foekens, A. M. Sieuwerts, M. Smid, M. P. Look, V. de Weerd, A. W. M. Boersma, J. G. M. Klijn, E. A. C. Wiemer, and J. W. M. Martens Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer PNAS, September 2, 2008; 105(35): 13021 - 13026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1600 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yang, W. Kong, L. He, J.-J. Zhao, J. D. O'Donnell, J. Wang, R. M. Wenham, D. Coppola, P. A. Kruk, S. V. Nicosia, et al. MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN Cancer Res., January 15, 2008; 68(2): 425 - 433. [Abstract] [Full Text] [PDF]
|
|
